SCHEMBL2790682

SCHEMBL2790682

COc1ccc2c(c1)S(=O)(=O)N=NC2C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
POLB P06746 1/20 0.37
HTR2C P28335 1/20 0.36
BRD4 O60885 1/20 0.35
ALDH1A1 P00352 5/20 0.34
LMNA P02545 2/20 0.33
GRIA2 P42262 2/20 0.33
ATM Q13315 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33
SLC10A2 Q12908 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2792799 0.64 CA2 (0.40) CA2KDM4ECA12CA1CA4
SCHEMBL8285731 0.62 PTGES (0.44) CA2KDM4EMAPTKMT2ACA12
SCHEMBL2353218 0.61 ADRA1D (0.46) CA2KDM4EMAPTKMT2ACA12
SCHEMBL18740669 0.61 PTGES (0.43) CA2KDM4EMAPTKMT2ACA12
SCHEMBL22827702 0.61 CA2 (0.42) CA2KDM4EMAPTKMT2ACA12
SCHEMBL22827735 0.60 CA2 (0.41) CA2KDM4EMAPTKMT2ACA12
SCHEMBL5184948 0.60 SHMT2 (0.61) CA2KDM4EMAPTKMT2ACA12
SCHEMBL32667840 0.60 MAPT (0.65) CA2KDM4EMAPTKMT2ACA12
SCHEMBL5183853 0.59 CYP1A2 (0.43) CA2KDM4EMAPTKMT2ACA12
SCHEMBL10727722 0.59 ABCC8 (0.63) CA2KDM4EMAPTKMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168087-A1 BENZO[1,2,3]THIADIAZINE DERIVATES EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) 2010-07-01 US disclosed
EP-2061777-A1 BENZOÝ1,2,3¨THIADIAZINE DERIVATIVES Egis Gyogyszergyar Nyilvánosan Múködó Részvénytársaság (HU) 2009-05-27 EP disclosed
WO-2008020255-A1 BENZO[1,2,3]THIADIAZINE DERIVATIVES EGIS GYÓGYSZERGYÁR Nyilvánosan Müködö Részvénytársagág (HU) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168087-A1 BENZO[1,2,3]THIADIAZINE DERIVATES SULT2A1, TPH1, CYP1A1 CA2 1484/4885KDM4E 3186/4885MAPT 1540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.